Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Study reveals wasteosomes as markers of chronic glymphatic system insufficiency

A new study led by researchers from the University of Barcelona shows that wasteosomes - structures that act as containers for brain waste products - indicate a malfunction of the glymphatic system, a recently discovered system that is an important brain-cleaning mechanism.

30 Nov 2022

Research findings may offer a new potential therapeutic target for Alzheimer’s disease

A new study links a gene concentrated in the brain's cleanup cells, known as microglia, to the inflammation that has increasingly emerged as a key mechanism contributing to Alzheimer's disease.

30 Nov 2022

Study reveals a more nuanced relationship between work demands and a good night's sleep

Conventional wisdom suggests that people with the most demanding jobs would have the most trouble sleeping.

30 Nov 2022

Study identifies a urinary biomarker to reveal early-stage Alzheimer’s disease

Could a simple urine test reveal if someone has early-stage Alzheimer’s disease and could this pave the way for large-scale screening programs? A new study in Frontiers in Aging Neuroscience certainly suggests so. The researchers tested a large group of patients with Alzheimer’s disease of different levels of severity and healthy controls with normal cognition to identify differences in urinary biomarkers.

30 Nov 2022

Interprofessional primary care for dementia patients linked with increased ER visits

Individuals with dementia require care from a variety of healthcare providers. Interprofessional team care has been touted as most beneficial to this patient population.

29 Nov 2022

Study links MAIT cells to cognitive function

Could the underproduction of poorly understood immune cells contribute to Alzheimer's disease and other forms of cognitive decline? A Rutgers study in Nature Immunology suggests it may – and that increasing these cells could reverse the damage.

29 Nov 2022

Activation of microglial cells can slow down Alzheimer's progression

The brain's big-eating immune cells can slow down the progression of Alzheimer's disease. This is shown by a study that is now published in Nature Aging.

29 Nov 2022

Rural Colorado tries to fill health worker gaps with apprenticeships

During her 12-hour overnight shift, Brianna Shelton helps residents at BeeHive Homes Assisted Living go to the bathroom. Many of them have dementia, and some can't get out of bed on their own. Only a few can remember her name, but that doesn't matter to her.

29 Nov 2022

Study reveals a promising therapeutic target for Alzheimer's disease

In a recent search for gene variants associated with Alzheimer's disease (AD), several affected families showed a mutation in an enzyme called protein kinase C-alpha (PKCα). Family members with this mutation had AD; those without the mutation did not.

28 Nov 2022

Machine learning pinpoints the most accurate timelines for predicting Alzheimer's progression

A Cornell-led collaboration used machine learning to pinpoint the most accurate means, and timelines, for anticipating the advancement of Alzheimer's disease in people who are either cognitively normal or experiencing mild cognitive impairment.

28 Nov 2022

Green Mediterranean diet causes significant reduction in visceral adipose tissue

The green Mediterranean diet (MED) significantly reduces visceral adipose tissue, a type of fat around internal organs that is much more dangerous than the extra "tire" around your waist.

28 Nov 2022

Molecular and cellular similarities identified in the brains of SARS-CoV-2 and Alzheimer's disease patients

Researchers evaluated neuro-pathophysiological consequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, especially the post-acute sequelae of SARS-CoV-2 (PASC) in Alzheimer’s disease (AD) patients.

28 Nov 2022

Using human iPSC-derived cells to revolutionize the field of neurodegenerative disease

In this interview, we speak to Axol Bioscience about their human iPSC-derived cells and how they have the potential to revolutionize the field of neurodegenerative disease.

From Axol Bioscience Ltd 28 Nov 2022

Should older seniors risk major surgery? New research offers guidance

Nearly 1 in 7 older adults die within a year of undergoing major surgery, according to an important new study that sheds much-needed light on the risks seniors face when having invasive procedures.

28 Nov 2022

Government introduces a Vaccine Taskforce style approach to tackle public health challenges in the UK

NHS patients are set to benefit from cutting-edge new treatments and technologies as the government introduces a Vaccine Taskforce style approach to tackling some of the biggest public health challenges facing the UK.

27 Nov 2022

The distinct pathophysiology of ‘SuperAger’ brains

Superagers are adults over the age of 80 who have a superior memory capacity that resembles that of middle-aged adults.

27 Nov 2022

Klotho protein levels protect against cognitive decline in Alzheimer patients

Researchers compare Klotho protein levels of healthy individuals and patients diagnosed with different stages of Alzheimer’s disease.

27 Nov 2022

Astrocytes in the brains of epileptic mice exhibit an acid response with intensified seizures

Researchers at Tohoku University have shown that astrocytes in the mouse brain exhibit an acid response with intensified epileptic seizures.

25 Nov 2022

New biomarker can help identify people with a primary tauopathy

Zooming in on a single disease and studying it intensely is often the most productive route to finding treatments. But there's no easy way to distinguish among people living with any of the primary tauopathies - a group of rare brain diseases marked by rapidly worsening problems with thinking and movement - because the symptoms are too similar.

24 Nov 2022

Two new studies identify potential risk factors associated with frontotemporal dementia

Two recent studies from the University of Eastern Finland show that educational background and previous traumatic brain injury may potentially affect the risk of frontotemporal dementia.

24 Nov 2022

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Study reveals wasteosomes as markers of chronic glymphatic system insufficiency

Research findings may offer a new potential therapeutic target for Alzheimer’s disease

Study reveals a more nuanced relationship between work demands and a good night's sleep

Study identifies a urinary biomarker to reveal early-stage Alzheimer’s disease

Interprofessional primary care for dementia patients linked with increased ER visits

Study links MAIT cells to cognitive function

Activation of microglial cells can slow down Alzheimer's progression

Rural Colorado tries to fill health worker gaps with apprenticeships

Study reveals a promising therapeutic target for Alzheimer's disease

Machine learning pinpoints the most accurate timelines for predicting Alzheimer's progression

Green Mediterranean diet causes significant reduction in visceral adipose tissue

Molecular and cellular similarities identified in the brains of SARS-CoV-2 and Alzheimer's disease patients

Using human iPSC-derived cells to revolutionize the field of neurodegenerative disease

Should older seniors risk major surgery? New research offers guidance

Government introduces a Vaccine Taskforce style approach to tackle public health challenges in the UK

The distinct pathophysiology of ‘SuperAger’ brains

Klotho protein levels protect against cognitive decline in Alzheimer patients

Astrocytes in the brains of epileptic mice exhibit an acid response with intensified seizures

New biomarker can help identify people with a primary tauopathy

Two new studies identify potential risk factors associated with frontotemporal dementia

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in